TIDMCRYO 
 
RNS Number : 5972H 
Cryo-Save Group NV 
24 February 2010 
 

24 February 2010 
 
 
 
Cryo-Save Group NV, (AIM: CRYO), Europe's largest adult stem cell storage bank, 
will be publishing its Full Year results for the 12 months ended 31 December 
2009 on Monday, 22 March 2010. 
 
A presentation for analysts will be held at 9.30am on 22 March at the offices of 
College Hill, The Registry, Royal Mint Court, London, EC3N 4QN. 
 
Enquiries: 
 
+-------------------------------+----------------------------+ 
| Cryo-Save Group               |       + 31 (0) 575 548 998 | 
+-------------------------------+----------------------------+ 
| Marc Waeterschoot, Chief      |                            | 
| Executive                     |                            | 
| Arnoud van Tulder, Chief      |                            | 
| Financial Officer             |                            | 
+-------------------------------+----------------------------+ 
|                               |                            | 
+-------------------------------+----------------------------+ 
| Daniel Stewart & Company plc  |      + 44 (0) 20 7776 6550 | 
+-------------------------------+----------------------------+ 
| Simon Leathers / Emma Earl    |                            | 
+-------------------------------+----------------------------+ 
|                               |                            | 
+-------------------------------+----------------------------+ 
| College Hill                  |      + 44 (0) 20 7457 2020 | 
+-------------------------------+----------------------------+ 
| Adrian Duffield/Rozi Morris   |                            | 
+-------------------------------+----------------------------+ 
 
About Cryo-Save 
 
With more than 120,000 samples saved, Cryo-Save is the leading stem cell bank in 
Europe and one of the fastest growing in the world.  Driven by its international 
business strategy, Cryo-Save is now represented in 38 countries on three 
continents and has state-of-the-art processing facilities in Belgium, Germany, 
Dubai, India and France (under construction). 
 
Cryo-Save sets the highest quality standards in stem cell storage, as it aims to 
make an important contribution to conquer possible life-threatening diseases in 
the future. As a service to the public, Cryo-Save offers a Cost-free Family 
Donation Programme, free of charge, to families wishing to store their newborn's 
umbilical cord blood stem cells for a family member diagnosed with a 
life-threatening disease treatable by stem cells. The company is committed to 
further improve stem cell cryopreservation techniques, by participating in 
European Commission funded projects, in Universities and Hospitals. 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 NORKZLBLBLFFBBX
Cryo-Save (LSE:CRYO)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024 Click aqui para mais gráficos Cryo-Save.
Cryo-Save (LSE:CRYO)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024 Click aqui para mais gráficos Cryo-Save.